Suppr超能文献

美国颅内动脉瘤性蛛网膜下腔出血患者脑梗死的患病率、趋势和结局。

Prevalence, trends, and outcomes of cerebral infarction in patients with aneurysmal subarachnoid hemorrhage in the USA.

机构信息

Zeenat Qureshi Stroke Institute, St. Cloud, Minnesota, USA.

Department of Neurology, University of Missouri, Columbia, Missouri, USA.

出版信息

J Neuroimaging. 2024 Nov-Dec;34(6):790-798. doi: 10.1111/jon.13229. Epub 2024 Sep 2.

Abstract

BACKGROUND AND PURPOSE

Cerebral infarction remains an important cause of death or disability in patients with aneurysmal subarachnoid hemorrhage (SAH). The prevalence, trends, and outcomes of cerebral infarction in patients with aneurysmal SAH at a national level are not known.

METHODS

We identified the proportion of patients who develop cerebral infarction (ascertained using validated methodology) among patients with aneurysmal SAH and annual trends using the Nationwide Inpatient Sample (NIS) from 2016 to 2021. We analyzed the effect of cerebral infarction on in-hospital mortality, routine discharge without palliative care (based on discharge disposition), poor outcome defined by the NIS SAH outcome measure, and length and costs of hospitalization after adjusting for potential confounders.

RESULTS

A total of 35,305 (53.6%) patients developed cerebral infarction among 65,840 patients with aneurysmal SAH over a 6-year period. There was a trend toward an increase in the proportion of patients who developed cerebral infarction from 51.5% in 2016 to 56.1% in 2021 (p trend p<.001). Routine discharge was significantly lower (30.5% vs. 37.8%, odds ratio [OR] 0.82, 95% confidence interval [CI] 0.75-0.89, p<.001), and poor outcome defined by NIS-SAH outcome measure was significantly higher among patients with cerebral infarction compared with those without cerebral infarction (67.4% vs. 59.3%, OR 1.29, 95% CI 1.18-1.40, p<.001). There was no difference in in-hospital mortality (13.0% vs. 13.6%, OR 0.94, 95% CI 0.85-1.05, p = .30). The length of stay (median 18 days [interquartile range [IQR] 13-25] vs. 14 days [IQR 9-20]), coefficient 3.04, 95% CI 2.44-3.52 and hospitalization cost (median $96,823 vs. $71,311, coefficient 22,320, 95% CI 20,053-24,587) were significantly higher among patients who developed cerebral infarction compared with those who did not develop cerebral infarction.

CONCLUSIONS

Cerebral infarction was seen in 54% of the patients with a trend toward an increase in the affected proportion of patients with aneurysmal SAH. Patients with cerebral infarction had higher rates of adverse outcomes and required higher resources during hospitalization.

摘要

背景与目的

脑梗死仍然是蛛网膜下腔出血(SAH)患者死亡或残疾的重要原因。在全国范围内,患有动脉瘤性蛛网膜下腔出血患者的脑梗死发生率、趋势和结局尚不清楚。

方法

我们使用全国住院患者样本(NIS)确定了 2016 年至 2021 年期间患有动脉瘤性 SAH 的患者中发生脑梗死的患者比例(使用经过验证的方法确定)和年度趋势。我们分析了脑梗死对住院死亡率、常规无姑息治疗出院(基于出院情况)、NIS-SAH 结局测量定义的不良结局以及调整潜在混杂因素后住院时间和住院费用的影响。

结果

在 6 年期间,共有 35305 名(53.6%)患有动脉瘤性 SAH 的患者发生脑梗死,其中 65840 名患者发生脑梗死。从 2016 年的 51.5%到 2021 年的 56.1%,发生脑梗死的患者比例呈上升趋势(趋势 p<.001)。与无脑梗死患者相比,常规出院率显著降低(30.5%比 37.8%,优势比[OR] 0.82,95%置信区间[CI] 0.75-0.89,p<.001),NIS-SAH 结局测量定义的不良结局更高(67.4%比 59.3%,OR 1.29,95% CI 1.18-1.40,p<.001)。脑梗死患者与无脑梗死患者的住院死亡率无差异(13.0%比 13.6%,OR 0.94,95% CI 0.85-1.05,p = 0.30)。脑梗死患者的住院时间(中位数 18 天[四分位距[IQR] 13-25]比 14 天[IQR 9-20]),系数 3.04,95% CI 2.44-3.52 和住院费用(中位数 96823 美元[95% CI 20053-24587]比 71311 美元)显著高于无脑梗死患者。

结论

在患有动脉瘤性蛛网膜下腔出血的患者中,有 54%的患者发生了脑梗死,并且患有动脉瘤性蛛网膜下腔出血的患者的脑梗死比例呈上升趋势。发生脑梗死的患者不良结局发生率更高,住院期间需要更多资源。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验